Pharmactive

Pharmactive biotech Products, S.L.U. is a Spanish biotechnology company specializing in the development and manufacturing of differentiated natural ingredients supported by scientific evidence. Founded in 2009, the company focuses on creating innovative botanical extracts for the nutraceutical, pharmaceutical, and veterinary industries. Pharmactive's product portfolio includes premium branded ingredients such as Affron, a saffron extract for mood improvement and stress management; ABG+, an aged black garlic extract for cardiovascular health; and Liboost for sexual health.

The company employs proprietary extraction processes using eco-friendly techniques that avoid alcohol-based elements or synthetic additives. These methods involve limited industrial processing, low energy consumption, and minimal waste production. As of 2023, Pharmactive operates on 100% renewable electricity and recycles water used during the extraction of its active ingredients. The company also ships its products in 100% recycled cardboard containers, demonstrating its commitment to environmental sustainability.

Pharmactive places a strong emphasis on scientific research and quality control. The company conducts rigorous quality checks at all stages of product development, from crop cultivation to final production, ensuring full traceability of its ingredients. Affron has been supported by ten clinical studies, while ABG+ has undergone two clinical trials. The company's laboratories are accredited by ENAC and hold ISO 9001:2015, 14001:2015, and 22000:2005 certifications.

In November 2023, Pharmactive achieved B Corporation certification, affirming its dedication to upholding high standards in social and environmental performance, transparency, and business excellence. The company's workforce is 60% female, with half of the management team being women. Pharmactive actively contributes to the development of local communities, working with farmers in Castilla-La Mancha for sourcing raw materials.

Key customers and partnerships

Pharmactive targets companies in the nutraceutical, pharmaceutical, and veterinary industries as its primary customers. In June 2022, the company entered a strategic partnership with Singapore-based Nutraconnect Pte, Ltd. to expand its presence in the Asia-Pacific market, excluding Australia and New Zealand. This collaboration aimed to connect Pharmactive with local and regional nutraceutical players seeking high-quality, pure ingredients.